Related Experiment Video
Updated: Aug 3, 2025

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Factors associated with the progression of aortic valve calcification in older adults
David Leibowitz1, Yuriko Yoshida2, Zhezhen Jin3
1Heart Institute, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Insights
Aortic valve calcification (AVC) progresses in many older adults. While common risk factors aren't linked, higher TGF-β1 levels are associated with AVC progression.
Area of Science:
- Cardiology
- Gerontology
- Biomarker Research
Background:
- Aortic valve calcification (AVC) is a common valvular abnormality leading to stenosis.
- Progression of AVC and its associated factors are not well understood.
- This study investigates factors influencing AVC progression in older adults.
Purpose of the Study:
- To identify clinical factors and serum biomarkers associated with aortic valve calcification progression.
- To analyze AVC progression in a population-based cohort of elderly individuals.
Main Methods:
- Utilized data from the Cardiovascular Abnormalities and Brain Lesion (CABL) and Subclinical Atrial Fibrillation And Risk of Ischemic Stroke (SAFARIS) studies.
- Assessed AVC severity using a 0-3 grading scale on echocardiography at baseline and follow-up.
- Measured serum biomarkers, including transforming growth factor beta 1 (TGF-β1), at follow-up.
Main Results:
- 373 participants (mean age 68.1 years) were analyzed; 37% showed AVC progression.
- Anti-hypertensive medication use was the sole clinical predictor of any AVC progression.
- Transforming growth factor beta 1 (TGF-β1) was significantly associated with both all and moderate-severe AVC progression.
Conclusions:
- A notable proportion of elderly individuals with AVC experience disease progression.
- Individual vascular risk factors were not significantly associated with AVC progression, suggesting a potential combined effect.
- Elevated TGF-β1 levels are linked to AVC progression in this cohort.
Background:
Aortic valve calcification (AVC) is a common valvular abnormality that predisposes to stenosis; AVC progression and factors associated with it remain unclear. We investigated the association of clinical factors and serum biomarkers with AVC progression in a population-based cohort of older adults.
Methods:
Participants enrolled in both the Cardiovascular Abnormalities and Brain Lesion study (CABL; years 2005-2010) and the Subclinical Atrial Fibrillation And Risk of Ischemic Stroke study (SAFARIS;2014-2019) represent the study cohort. AVC was defined as bright dense echoes >1 mm in size on ≥1 cusps; each cusp was graded on a scale of 0 (normal) to 3 (severe calcification) at baseline and follow up. Serum biomarkers were measured at the time of follow-up assessment.
Results:
373 participants (mean 68.1 ± 7.6 years of age, 146 M/ 227F) were included. 139 (37%) had AVC progression;93 (25%) had mild progression (1 grade), and 46 (12%) had moderate-severe progression (≥2 grades). The only significant clinical predictor of any progression was the use of anti-hypertensive medication which was associated with older age, higher BMI and more frequent hypertension, diabetes and hyperlipidemia. In multivariable analysis including biomarkers, transforming growth factor beta 1 (TGF-β1) was significantly associated with both all and moderate-severe AVC progression.
Conclusions:
A significant number of elderly subjects with AVC show progression of their valve disease; individual vascular risk factors are not associated with AVC progression, although a combined effect may exist. Higher levels of TGF-β1 are observed in individuals with AVC progression.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation I: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Atherosclerosis I: Introduction
Aortic Regurgitation III: Medical Management

